These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1245319)
1. Law in brief: liability for drug reactions. Bernstein AH Hospitals; 1976 Jan; 50(1):111-2. PubMed ID: 1245319 [No Abstract] [Full Text] [Related]
2. The eye and adverse drug effects. Some selected considerations. Robertson DM Minn Med; 1972 Oct; 55(10):927-34 passim. PubMed ID: 4628654 [No Abstract] [Full Text] [Related]
3. [Etiology and pathogenesis of toxic side-effects of drugs on the retina (author's transl)]. Meier-Ruge W Klin Monbl Augenheilkd; 1973 Aug; 163(2):155-72. PubMed ID: 4761731 [No Abstract] [Full Text] [Related]
4. [Responsibility for adverse drug effects]. Naess K Tidsskr Nor Laegeforen; 1971 Mar; 91(9):673-6. PubMed ID: 5576192 [No Abstract] [Full Text] [Related]
5. Oral contraceptives and their relationship to cancer of the breast: a medicolegal problem. Clasper RK Med Trial Tech Q; 1977; 24(1):61-82. PubMed ID: 916868 [No Abstract] [Full Text] [Related]
6. [Eye diseases caused by drugs]. Henkes HE Ned Tijdschr Geneeskd; 1970 Jul; 114(27):1140-4. PubMed ID: 5447871 [No Abstract] [Full Text] [Related]
8. The medicolegal aspects of adverse drug reactions. Bernstein HN; Levine AM Int Ophthalmol Clin; 1970; 10(3):455-72. PubMed ID: 5537801 [No Abstract] [Full Text] [Related]
9. [Liability for drug damages]. Barnikel W Dtsch Med Wochenschr; 1977 Jan; 102(4):139. PubMed ID: 832595 [No Abstract] [Full Text] [Related]
11. Enterprise liability for bad outcomes from drug therapy: the doctor, the hospital, the pharmacy, and the drug firm. Furrow BR Spec Law Dig Health Care Law; 1998 Apr; (229):9-69. PubMed ID: 10178162 [No Abstract] [Full Text] [Related]
12. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption. Poser S Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225 [No Abstract] [Full Text] [Related]
13. Point of law: what are the legal implications of prescribing and administering FDA-approved drugs in nonapproved ways? Kaunitz AM Hosp Med Staff; 1982 Feb; 11(2):15-8. PubMed ID: 10254209 [No Abstract] [Full Text] [Related]
14. [Effect of drugs on the eye]. Jaros Z Cas Lek Cesk; 1970 Mar; 109(11):253-5. PubMed ID: 4914615 [No Abstract] [Full Text] [Related]
15. New warnings on the way for oral contraceptives. Zimmerly JG J Leg Med (N Y); 1977 Feb; 5(2):23-4. PubMed ID: 299872 [No Abstract] [Full Text] [Related]
16. [Responsibility for drug reactions]. Naess K Nord Med; 1975 Mar; 90(3):65-6. PubMed ID: 1153254 [No Abstract] [Full Text] [Related]
17. [Proposal for insurance against drug-induced disorders]. Bergvall G Nord Med; 1975 Sep; 90(8-9):221-2. PubMed ID: 1165991 [No Abstract] [Full Text] [Related]
18. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization. Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220 [TBL] [Abstract][Full Text] [Related]
19. Food and Drug Administration. Tempest over polio vaccine. Anderson C Nature; 1991 Jun; 351(6327):510. PubMed ID: 2046758 [No Abstract] [Full Text] [Related]
20. Paul Offit. Oransky I Lancet; 2005 Dec; 366(9502):1999. PubMed ID: 16338442 [No Abstract] [Full Text] [Related] [Next] [New Search]